subscribeSubscribe
price-trendAsk Us
Zai Lab eyes imminent China filing for MacroGenics` HER2 drug

Zai Lab eyes imminent China filing for MacroGenics` HER2 drug
Amber Tong ENDPTS
06 Oct 2021
Share Share
MacroGenics flips over an OS dud for Margenza in turnaround from earlier data

MacroGenics flips over an OS dud for Margenza in turnaround from earlier data
K. Blankenship ENDPTS
08 Sep 2021
Share Share
MacroGenics Announces Lancet Oncology Publication of Margetuximab Data

MacroGenics Announces Lancet Oncology Publication of Margetuximab Data
GLOBENEWSWIRE
10 Jul 2020
Share Share
MacroGenics Announces Margetuximab Granted Orphan Drug Designation in the U.S.

MacroGenics Announces Margetuximab Granted Orphan Drug Designation in the U.S.
PRESS RELEASE
05 Jun 2020
Share Share
MacroGenics Provides Update on FDA Review of Margetuximab for HER2-Positive MBC

MacroGenics Provides Update on FDA Review of Margetuximab for HER2-Positive MBC
GLOBENEWSWIRE
28 May 2020
Share Share
MacroGenics Announces Submission of Margetuximab Biologics License Application

MacroGenics Announces Submission of Margetuximab Biologics License Application
PRESS RELEASE
19 Dec 2019
Share Share
MacroGenics` margetuximab nets OS gain in advanced breast cancer

MacroGenics` margetuximab nets OS gain in advanced breast cancer
Conor Hale FIERCE BIOTECH
11 Dec 2019
Share Share
Macrogenics` margetuximab shows survival benefit in late-stage breast cancer

Macrogenics` margetuximab shows survival benefit in late-stage breast cancer
Douglas W. House SEEKINGALPHA
23 Oct 2019
Share Share
Macrogenics` margetuximab shows survival benefit in late-stage breast study

Macrogenics` margetuximab shows survival benefit in late-stage breast study
Douglas W. House SEEKINGALPHA
22 Oct 2019
Share Share
MacroGenics reports positive results from phase 3 Sophia study of margetuximab

MacroGenics reports positive results from phase 3 Sophia study of margetuximab
PHARMA BIZ
08 Feb 2019
Share Share